Adjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 VESTIGE study.

Autor: Lordick F; Department of Medicine (Oncology, Gastroenterology, Hepatology, Pulmonology), University of Leipzig Medical Center, Comprehensive Cancer Center Central Germany (CCCG), Leipzig, Germany. Electronic address: florian.lordick@medizin.uni-leipzig.de., Mauer ME; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium., Stocker G; Department of Medicine (Oncology, Gastroenterology, Hepatology, Pulmonology), University of Leipzig Medical Center, Comprehensive Cancer Center Central Germany (CCCG), Leipzig, Germany., Cella CA; Istituto Europeo di Oncologia, IRCCS, Milano, Italy., Ben-Aharon I; Rambam Health Care Campus, Department of Oncology, Haifa, Israel., Piessen G; CHRU de Lille - Hôpital Huriez, Lille, France., Wyrwicz L; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Al-Haidari G; Oslo University Hospital - Ullevaal Hospital, Oslo, Norway., Fleitas-Kanonnikoff T; Hospital Clinico Universitario De Valencia, Incliva Biomedical Research Institute, Valencia, Spain., Boige V; Department of Cancer Medicine, Institut Gustave Roussy, Villejuif, France., Obermannová RL; Department of Comprehensive Cancer Care Masaryk Memorial Cancer Institute and Faculty of Medicine, Masaryk University Brno, Czech Republic., Martens UM; Department of Oncology, SLK-Kliniken Heilbronn, Heilbronn, Germany., Gomez-Martin C; Hospital Universitario 12 De Octubre, Madrid, Spain., Thuss-Patience P; Charite - Universitaetsmedizin Berlin - Campus Virchow-Klinikum, Berlin, Germany., Arrazubi V; Hospital Universitario de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain., Avallone A; Istituto Nazionale Tumori- IRCCS - Fondazione G. Pascale, Napoli, Italy., Shiu KK; University College Hospital, London, United Kingdom., Artru P; Hôpital Privé Jean Mermoz, Lyon, France., Brenner B; Rabin Medical Center, Beilinson Hospital, Petach Tikva, and Tel-Aviv University, Ramat Aviv, Tel-Aviv, Israel., Sanchez CB; Department of Medical Oncology. ICO- Badalona (Catalan Institute of Oncology - Badalona), Barcelona, Spain., Chau I; Royal Marsden Hospital, London & Surrey, United Kingdom., Lorenzen S; Department of Haematology and Oncology, Klinikum rechts der Isar, Technische Universitaet Muenchen, Munich, Germany., Daum S; Charite - Universitaetsmedizin Berlin - Campus Benjamin-Franklin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Gastroenterology, Infectious Diseases and Rheumatology, Berlin, Germany., Sinn M; University Medical Center Hamburg-Eppendorf, Center of Oncology, Hamburg, Germany., Merelli B; Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy., van Grieken NCT; Department of Pathology, Amsterdam UMC location VUmc-Amsterdam, VU University, Amsterdam; Cancer Center Amsterdam, Amsterdam, The Netherlands., Nilsson M; Division of Surgery and Oncology, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet and Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden., Collienne M; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium., Giraut A; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium., Smyth E; Oxford NIHR Biomedical Research Centre, Churchill Hospital, Oxford, UK.

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Nov 12. Date of Electronic Publication: 2024 Nov 12.